Name | IDO-IN-8 |
---|---|
Synonyms |
5H-Imidazo[5,1-a]isoindole-5-ethanol, 6-fluoro-α-(trans-4-hydroxycyclohexyl)-, (αS,5R)-
trans-4-{(1S)-2-[(5R)-6-Fluoro-5H-imidazo[5,1-a]isoindol-5-yl]-1-hydroxyethyl}cyclohexanol |
Description | IDO-IN-8 (NLG-1487) is an indoleamine 2,3-dioxygenase (IDO) inhibitor extracted from patent WO WO2012142237A1, compound 1487, has an IC50 of 1-10 μM. |
---|---|
Related Catalog | |
Target |
IDO:1-10 μM (IC50) |
In Vitro | IDO-IN-8 (Compound 1487) is an indoleamine 2,3-dioxygenase (IDO) inhibitor with an IC50 of 1-10 μM (this is the concentration of IDO-IN-8 at which inhibits 50% of enzymatic activity using recombinant human IDO)[1]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 555.4±35.0 °C at 760 mmHg |
Molecular Formula | C18H21FN2O2 |
Molecular Weight | 316.370 |
Flash Point | 289.7±25.9 °C |
Exact Mass | 316.158691 |
LogP | 1.28 |
Vapour Pressure | 0.0±1.6 mmHg at 25°C |
Index of Refraction | 1.683 |
Storage condition | 2-8℃ |